Matthew Edward Kollada

This inventor holds 8 USPTO granted patents and 7 published patent applications. Top assignees: Neumora Therapeutics, Inc., Blackthorn Therapeutics, Inc.. Active years: 2022-2024.

USPTO Granted Patents = 8 (Patent Applications = 7)

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 4(Granted Patents)

Location History:

San Francisco, CA (US) (2022 - 2024)
Deerfield, IL (US) (2023 - 2024)

Company Filing History:

6 out of 20

Neumora Therapeutics, Inc.

patents

2 out of 9

Blackthorn Therapeutics, Inc.

patents

Years Active: 2022-2024

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12087446 - Multimodal dynamic attention fusion (2024-09-10),

2. 11942224 - System and method for identifying transdiagnostic features shared across mental health disorders (2024-03-26),

3. 11887724 - Estimating uncertainty in predictions generated by machine learning models (2024-01-30),

4. 11798681 - Machine learning systems for training encoder and decoder neural networks (2023-10-24),

5. 11742076 - Machine learning systems for generating multi-modal data archetypes (2023-08-29),

6. 11670417 - Machine learning systems for processing multi-modal patient data (2023-06-06),

7. 11289187 - Multimodal biomarkers predictive of transdiagnostic symptom severity (2022-03-29),

8. 11244762 - System and method for identifying transdiagnostic features shared across mental health disorders (2022-02-08),

Title: The Innovative Mind of Matthew Edward Kollada

Introduction

Matthew Edward Kollada is a prominent inventor based in Deerfield, IL (US). He has made significant contributions to the field of mental health diagnostics through his innovative patents. With a total of 8 patents to his name, Kollada is recognized for his work in utilizing machine learning to enhance mental health assessments.

Latest Patents

One of his latest patents is titled "Multimodal dynamic attention fusion." This invention provides methods and systems for diagnosing mental health conditions using multiple data modalities. A trained machine learning model is employed for mental health diagnosis, utilizing a dynamic fusion approach to capture and preserve interactions and timing information between various data modalities. Another notable patent is "System and method for identifying transdiagnostic features shared across mental health disorders." This system evaluates the mental health of patients by processing a selection of answers from mental health questionnaires and unprocessed MRI data. The integration of these elements allows for a comprehensive mental health indication of the patient.

Career Highlights

Kollada has worked with several notable companies, including Neumora Therapeutics, Inc. and Blackthorn Therapeutics, Inc. His experience in these organizations has contributed to his expertise in mental health technologies and machine learning applications.

Collaborations

Some of his coworkers include Tathagata Banerjee and Monika Sharma Mellem. Their collaborative efforts have further advanced the research and development of innovative solutions in mental health diagnostics.

Conclusion

Matthew Edward Kollada's contributions to the field of mental health through his patents and collaborations highlight his innovative spirit and dedication to improving diagnostic methods. His work continues to pave the way for advancements in mental health technology.